Geneuro

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Geneuro

Postby watoo75 » Sun Jun 24, 2018 12:05 am

https://youtu.be/QN3Zh648jN4

Biotech Showcase™: GeNeuro homes in on ancestral viral genes to treat autoimmune diseases

Focusing on an idea that many autoimmune diseases are caused by proteins from viral genes that are now embedded in human DNA, Swiss biotech GeNeuro is using the approach to tackle diseases such as multiple sclerosis and type 1 diabetes. Indeed, 8% of the human genome comes from genes left there by infections that affected our ancestors. Speaking at the 2018 Biotech Showcase, GeNeuro co-founder and CEO Jesús Martin-Garcia explained to Scrip how the company is advancing therapeutic candidates designed to neutralize the causal factors encoded by human endogenous retroviruses that lead to autoimmune diseases. The company’s lead programs focusing multiple sclerosis, and partnered with Servier, and type 1 diabetes are currently in Phase II trials.
User avatar
watoo75
Newbie
 
Posts: 6
Joined: Sun Jun 03, 2007 3:00 pm
Location: PARIS

Advertisement

Re: Geneuro

Postby Leonard » Sun Jun 24, 2018 3:23 am

watoo75 wrote:https://youtu.be/QN3Zh648jN4

Biotech Showcase™: GeNeuro homes in on ancestral viral genes to treat autoimmune diseases

Focusing on an idea that many autoimmune diseases are caused by proteins from viral genes that are now embedded in human DNA, Swiss biotech GeNeuro is using the approach to tackle diseases such as multiple sclerosis and type 1 diabetes. Indeed, 8% of the human genome comes from genes left there by infections that affected our ancestors. Speaking at the 2018 Biotech Showcase, GeNeuro co-founder and CEO Jesús Martin-Garcia explained to Scrip how the company is advancing therapeutic candidates designed to neutralize the causal factors encoded by human endogenous retroviruses that lead to autoimmune diseases. The company’s lead programs focusing multiple sclerosis, and partnered with Servier, and type 1 diabetes are currently in Phase II trials.



is it ancestral viral genes or is it more recent (40 - 100 M years old) EBV?

it would seem that EBV B cells are causal; they react with common epitopes on EBV infected cells when they come to expression.
this causes oxidative stress, successive mitochondrial failure, degeneration etc.

perhaps some epitopes from HERV have common characteristics with EBV.
in that case, old viral remains may add to our problem.
User avatar
Leonard
Family Elder
 
Posts: 949
Joined: Fri Dec 18, 2009 4:00 pm
Location: Brussels, Capital of Europe

Re: Geneuro

Postby watoo75 » Mon Jun 25, 2018 12:00 pm

Sure that gmbac1 is the solution
User avatar
watoo75
Newbie
 
Posts: 6
Joined: Sun Jun 03, 2007 3:00 pm
Location: PARIS

Re: Geneuro

Postby watoo75 » Wed Jun 27, 2018 11:24 am

Gnbac1 is the key.
User avatar
watoo75
Newbie
 
Posts: 6
Joined: Sun Jun 03, 2007 3:00 pm
Location: PARIS


Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service